# Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients

> **NCT07073768** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Khyber Medical College, Peshawar** · enrollment: 126 (estimated)

## Conditions studied

- Diabetes Mellitus Type 2
- Glycemic Control for Diabetes Mellitus

## Interventions

- **DRUG:** Trelagliptin 100 mg
- **DRUG:** Sitagliptin 100mg OD

## Key facts

- **NCT ID:** NCT07073768
- **Lead sponsor:** Khyber Medical College, Peshawar
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-07-01
- **Primary completion:** 2026-12-26
- **Final completion:** 2026-12-30
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07073768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07073768, "Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07073768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*